RECORNEA Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $15M

  • Investors
  • 12

RECORNEA General Information

Description

Developer of a corneal medical device designed to restore the physiological curvature of the cornea with clear and predictable clinical outcomes. The company's device utilizes an implantable medical technology capable of improving the vision of patients suffering from keratoconus, enabling healthcare professionals to treat their patients with various pathological conditions that cause deformation of the cornea.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via della Ginnastica 9
  • 34125 Trieste
  • Italy
+39 320
Primary Industry
Therapeutic Devices
Corporate Office
  • Via della Ginnastica 9
  • 34125 Trieste
  • Italy
+39 320

RECORNEA Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RECORNEA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series A) 18-Nov-2024 $15M Completed Clinical Trials - Phase 1
11. Later Stage VC 15-Mar-2025 Completed Clinical Trials - Phase 1
10. Accelerator/Incubator 26-Sep-2024 Completed Clinical Trials - Phase 1
9. Accelerator/Incubator 25-Oct-2022 Completed Clinical Trials - Phase 1
8. Early Stage VC (Series B) 17-Jan-2022 Completed Clinical Trials - Phase 1
7. Accelerator/Incubator 12-Oct-2020 Completed Clinical Trials - Phase 1
6. Accelerator/Incubator 01-Jun-2020 Completed Clinical Trials - Phase 1
5. Early Stage VC (Series A) 12-May-2020 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator 01-Feb-2020 $100K $330K Completed Clinical Trials - Phase 1
3. Seed Round $123K $230K Completed Clinical Trials - Phase 1
To view RECORNEA’s complete valuation and funding history, request access »

RECORNEA Patents

RECORNEA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4665271-A1 Corneal implant Pending 13-Feb-2023
US-20260224349-A1 Corneal implant Pending 13-Feb-2023
WO-2024170950-A8 Corneal implant Inactive 13-Feb-2023
EP-3801386-A1 Corneal implant Active 08-Jun-2018
EP-3801386-B1 Corneal implant Active 08-Jun-2018 A61F2/14
To view RECORNEA’s complete patent history, request access »

RECORNEA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RECORNEA Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caique Holding Corporation Minority
DN Lemans Corporation Minority
Scientifica Venture Capital Minority
Tech and Biomedical Foundation Venture Capital Minority
EIT Health Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

RECORNEA FAQs

  • When was RECORNEA founded?

    RECORNEA was founded in 2019.

  • Where is RECORNEA headquartered?

    RECORNEA is headquartered in Trieste, Italy.

  • What is the size of RECORNEA?

    RECORNEA has 6 total employees.

  • What industry is RECORNEA in?

    RECORNEA’s primary industry is Therapeutic Devices.

  • Is RECORNEA a private or public company?

    RECORNEA is a Private company.

  • What is RECORNEA’s current revenue?

    The current revenue for RECORNEA is .

  • How much funding has RECORNEA raised over time?

    RECORNEA has raised $19.6M.

  • Who are RECORNEA’s investors?

    Caique Holding, DN Lemans, Scientifica, Tech and Biomedical Foundation, and EIT Health are 5 of 12 investors who have invested in RECORNEA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process